NeuroOne Medical Technologies Co. (NASDAQ:NMTC) Short Interest Down 15.5% in April

NeuroOne Medical Technologies Co. (NASDAQ:NMTC) saw a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 308,500 shares, a decrease of 15.5% from the March 31st total of 365,300 shares. Based on an average trading volume of 194,700 shares, the short-interest ratio is presently 1.6 days. Currently, 1.4% of the company’s stock are sold short.

NeuroOne Medical Technologies Price Performance

NASDAQ:NMTC opened at $1.13 on Monday. NeuroOne Medical Technologies has a 52 week low of $0.85 and a 52 week high of $2.00. The firm has a 50 day moving average of $1.17 and a 200 day moving average of $1.26.

NeuroOne Medical Technologies (NASDAQ:NMTC) last posted its earnings results on Tuesday, February 13th. The company reported ($0.14) EPS for the quarter. NeuroOne Medical Technologies had a negative net margin of 478.41% and a negative return on equity of 267.82%. The firm had revenue of $0.98 million for the quarter.

Institutional Investors Weigh In On NeuroOne Medical Technologies

An institutional investor recently bought a new position in NeuroOne Medical Technologies stock. Perkins Capital Management Inc. bought a new stake in shares of NeuroOne Medical Technologies Co. (NASDAQ:NMTC) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 150,000 shares of the company’s stock, valued at approximately $134,000. Perkins Capital Management Inc. owned about 0.63% of NeuroOne Medical Technologies as of its most recent SEC filing. 16.07% of the stock is owned by hedge funds and other institutional investors.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders.